Cipher Surgical investment provides scope for growth
8 April 2011 Pictured above: (l-r) Andrew Newell, Tim Powell, Ian Mackenzie, Piyush Patel and…
read moreCipher Surgical’s first product aims to solve a key challenge facing surgeons in the fast growing field of laparoscopy (keyhole surgery through the abdomen), that of maintaining continuous operative visions. A laparoscope transmits an image of the operative site to a screen, acting as the surgeon’s eyes but the lens can become soiled by blood, fat, condensation and other contaminants. To clean it, which can happen 6-10 times per hour, the laparoscope is removed from the patient and cleaned manually. As a result the surgeon’s work flow and concentration is broken and patient risk in increased. The Laparojet is a patentable disposable which retrofits all laparoscopes and, activated by the surgeon, delivers a jet of carbon dioxide across the lens, to clear instantly. The Laparojet is expected to be launched in Europe in 2012.
Status current
Associated Fund Early Advantage Fund
Sector Medical / Biotechnology
Website www.ciphersurgical.com/
8 April 2011 Pictured above: (l-r) Andrew Newell, Tim Powell, Ian Mackenzie, Piyush Patel and…
read moreIn a £44bn industry, with no single versatile solution to lens contamination, Cipher Surgical...
read moreCipher Surgical Limited will be exhibiting at the 23rd International Congress of the European Association...
read moreUpdate your browser to view this website correctly.Update my browser now